Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD‐02 study design and first results

Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD‐02 study design and first results

Primary prevention of type 1 diabetes (T1D) requires intervention in genetically at‐risk infants. The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) has established a screening program, GPPAD‐02, that identifies infants with a genetic high risk of T1D, enrolls these into primary p...

Full description

Bibliographic Details
Main Authors: Winkler, C, Haupt, F, Heigermoser, M, Zapardiel-Gonzalo, J, Ohli, J, Faure, T, Kalideri, E, Hommel, A, Delivani, P, Berner, R, Kordonouri, O, Roloff, F, Von Dem Berge, T, Lange, K, Oltarzewski, M, Glab, R, Szypowska, A, Snape, M, Vatish, M, Todd, J, Larsson, H, Ramelius, A, Kördel, J, Casteels, K, Paulus, J, Ziegler, A, Bonifacio, E, GPPAD Study Group
Format: Journal article
Language:English
Published: Wiley 2019

Similar Items